Mucins and Toll-like Receptors in Asthma
NCT02948153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43
Last updated 2016-10-28
Summary
This study raises two main hypotheses: 1) Asthmatics patients who present with bronchial hypersecretion differ phenotypically from asthmatic patients without hypersecretion and 2) mucins in asthmatic patients with hypersecretion of bronchial mucus and the expression of TLRs differ from non-mucus hypersecretory asthmatics patients.
Conditions
Interventions
- OTHER
-
clinical study
It is a comprehensive study in a large sample using multiple techniques to assess various aspects of the disease. All patients underwent the following : Induced Sputum, spirometry, fractional exhaled nitric oxide (FeNO), prick test, total IgE and blood albumin. Analysis of mucins and TLRs
Sponsors & Collaborators
-
Spanish Respiratory Society
collaborator OTHER -
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
lead OTHER
Principal Investigators
-
Astrid Crespo, MD,PHD · Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-09-30
- Completion
- 2016-04-30
Countries
- Spain
Study Locations
More Related Trials
-
Microbiome and Exacerbations in Neutrophilic Asthma
NCT04260282 ·Status: UNKNOWN
-
Induction of Allergen Specific Bronchial Immunotolerance After Specific Immunotherapy
NCT01479205 ·Status: COMPLETED
-
Effectiveness of Anti-IL-5/IL5R Inhibitors
NCT06239441 ·Status: COMPLETED
-
Role of microRNAs in T Cell-Driven Inflammation in Asthma
NCT01484691 ·Status: COMPLETED ·Phase: NA
-
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
NCT01589198 ·Status: COMPLETED
-
Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069
NCT01890148 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines
NCT04412044 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
NCT06015256 ·Status: RECRUITING ·Phase: NA
-
Total IgE (Immunoglobulin E) and Der p 1 (d1) Specific IgE in Induced Sputum in Patients With Allergic and Non-allergic Asthma
NCT03640936 ·Status: COMPLETED
-
Inflammatory and Immune Profiles During a Severe Exacerbation in Preschool Asthmatic Children (<5 Years)
NCT03960359 ·Status: ACTIVE_NOT_RECRUITING
-
Severe Asthma Exacerbations and Mepolizumab Treatment
NCT04914078 ·Status: UNKNOWN
-
Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion
NCT05787678 ·Status: RECRUITING
-
Factors Involved in Asthma and Airway Inflammation
NCT00001887 ·Status: COMPLETED
-
The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics
NCT00784459 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma
NCT01007149 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)
NCT04808518 ·Status: COMPLETED
-
Immune Interactions in Severe Asthma
NCT02566668 ·Status: COMPLETED
-
Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma
NCT00980707 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection
NCT02491684 ·Status: COMPLETED ·Phase: PHASE2
-
Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics
NCT00721097 ·Status: TERMINATED
-
Antibiotic Treatment of Recurrent Episodes of Asthma in Children
NCT01233297 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of Symbicort on GR Localisation in Asthma
NCT00159263 ·Status: COMPLETED ·Phase: NA
-
Endotoxin and Bronchial Inflammation in Asthma
NCT00005550 ·Status: COMPLETED
-
Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
NCT00116311 ·Status: UNKNOWN